AHA Expresses Support for Comprehensive Bill on Medicare Advantage Reform

Why It Matters

By addressing systemic barriers in Medicare Advantage, the legislation could improve care continuity and financial stability for hospitals, while reshaping the risk‑adjusted payment landscape for insurers. The reforms also aim to protect beneficiaries from arbitrary denials, enhancing overall health system equity.

Key Takeaways

• AHA backs bipartisan Medicare Advantage Improvement Act (H.R. 8375/S. 4384).
• Bill targets excessive prior authorization in MA plans.
• Legislation mandates prompt payment standards for providers.
• Prohibits use of automated denial algorithms in claim reviews.
• Addresses post‑acute network adequacy to improve patient access.

Pulse Analysis

Medicare Advantage has become the dominant enrollment option for seniors, covering more than 40% of Medicare beneficiaries and accounting for roughly $1.5 trillion in annual spending. Critics argue that the rapid growth of private‑managed MA plans has introduced opaque utilization controls, such as aggressive prior‑authorization requirements and network restrictions, which can delay or deny essential services. Hospitals and physicians have reported rising administrative burdens and cash‑flow pressures, prompting calls for federal action to restore balance between cost containment and patient access.

The Medicare Advantage Improvement Act, introduced as H.R. 8375 and S. 4384, seeks to address these concerns through a suite of reforms. It would tighten prior‑authorization standards, requiring clearer clinical criteria and faster turnaround times, while also setting measurable post‑acute network adequacy benchmarks to ensure patients can receive timely rehabilitative care. A new prompt‑payment clause would obligate MA plans to reimburse providers within a defined window, reducing the lag that often forces hospitals to absorb unreimbursed costs. Perhaps most consequential is the prohibition of automated denial algorithms, mandating human review for complex claims and curbing the reliance on opaque AI-driven decisions.

For the healthcare industry, the bill represents a potential shift toward greater transparency and financial predictability. Hospitals could see reduced bad‑debt write‑offs and lower administrative overhead, while physicians may experience fewer care disruptions. Insurers, on the other hand, will need to adjust operational workflows and possibly absorb higher short‑term costs to comply with the new standards. If enacted, the legislation could set a precedent for federal oversight of private Medicare products, influencing future policy debates around value‑based care and market competition.